O
ATRC icon

OppenheimerFunds’s AtriCure ATRC Stock Holding History

OppenheimerFunds’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$10M Buy
375,085
+9,078
+2% +$276K 0.01% 668
2018
Q4 		$11.2M Buy
+366,007
New +$11.4M 0.02% 647
2017
Q3 		– Sell
-29,345
Closed -$712K – 1847
2017
Q2 		$712K Buy
29,345
+47
+0.2% +$999 ﹤0.01% 1330
2017
Q1 		$561K Buy
+29,298
New +$513K ﹤0.01% 1458

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

OppenheimerFunds's ATRC Position: Q1 2019 in Review

OppenheimerFunds increased its AtriCure (ATRC) stake by 2.5% in Q1 2019, buying an estimated $276K and bringing the position to 375,085 shares worth $10M. The position accounts for 0.01% of the portfolio, ranked #668.

OppenheimerFunds first reported a position in ATRC in Q1 2017 and has held it in 4 quarters since. The position peaked at $11.2M in Q4 2018. 160 funds tracked by Wall St. Rank hold ATRC as of Q1 2019.

  • OppenheimerFunds held 375,085 shares of AtriCure worth $10M as of Q1 2019.
  • OppenheimerFunds bought 9,078 AtriCure shares in Q1 2019, an estimated $276K.
  • AtriCure made up 0.01% of OppenheimerFunds's portfolio in Q1 2019, its #668 holding.
  • OppenheimerFunds first reported a position in AtriCure in Q1 2017 and has held it in 4 quarters since.
  • OppenheimerFunds's AtriCure position peaked at $11.2M in Q4 2018.
  • 160 funds tracked by Wall St. Rank held AtriCure as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.